2 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 2 |
Follow Lorlatinib 100 mg: new trials by email Literature Review of Lorlatinib 100 mg trials Research Report on Lorlatinib 100 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lorlatinib in ROS1+ NSCLC With Brain Metastasis Lorlatinib 100 mg - Lung Cancer (NSCLC) | Phase 2 | Not yet recruiting | Hunan Cancer Hospital | 21 | 2025-08-15 | 2025-07-24 |
| Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer Lorlatinib 100 mg - Neoadjuvant Non-Small Cell Lung Cancer | Phase 2 | Not yet recruiting | Peking University People's Hospital | 25 | 2024-11-15 | 2024-11-12 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
Hunan Cancer Hospital (1) · Peking University People's Hospital (1)
Fan F Yang, M.D. (1)